SVB Financial Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

SVB Financial Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,799	Closed	-$1.01M	–	23
2023 Q2	$1.01M	Sell	21,799 -7,267	-25%	-$251K	1.91%	6
2023 Q1	$833K	Sell	29,066 -13,292	-31%	-$394K	1.59%	8
2022 Q4	$1.32M	Buy	+42,358	New	+$1.38M	3.61%	6

SVB Financial Group's DICE Position: Q3 2023 in Review

SVB Financial Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 21,799 shares — an estimated $1.01M sold.

SVB Financial Group first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $1.32M in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

SVB Financial Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
SVB Financial Group sold 21,799 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.01M.
SVB Financial Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
SVB Financial Group's DICE Therapeutics, Inc. Common Stock position peaked at $1.32M in Q4 2022.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on SVB Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.